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Abstract
The 95 kDa transmembrane glycoprotein triadin is believed to be an essential component of excitation^contraction
coupling in the junctional sarcoplasmic reticulum of skeletal muscle fibers. It is debatable whether triadin mediates
intraluminal interactions between calsequestrin and the ryanodine receptor exclusively or whether this junctional protein
provides also a cytoplasmic linkage between the Ca2-release channel and the dihydropyridine receptor. Here, we could show
that native triadin exists as disulfide-linked homo-polymers of above 3000 kDa. Under non-reducing conditions, protein
bands representing the K1-dihydropyridine receptor and calsequestrin did not show an immunodecorative overlap with the
extremely high-molecular-mass triadin clusters. Following chemical crosslinking, the ryanodine receptor and triadin
exhibited a similarly decreased electrophoretic mobility. However, immunoblotting of diagonal non-reducing/reducing two-
dimensional gels clearly demonstrated a lack of overlap between the immunodecorated bands representing triadin, the
K1-dihydropyridine receptor, the ryanodine receptor and calsequestrin. Thus, in native membranes triadin appears to form
large self-aggregates primarily. Although triadin exists in a close neighborhood relationship to the Ca2-release channel
tetramers, it does not seem to be directly linked to the other main triad components implicated in the regulation of the
excitation^contraction^relaxation cycle and Ca2-homeostasis. This agrees with a proposed role of triadin in the
maintenance of overall triad architecture. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
In contrast to the proposed Ca2-induced Ca2-
release mechanism underlying cardiac excitation^
contraction coupling [1], signal transduction at skel-
etal muscle triads is thought to occur by means of
direct physical interactions between the transverse
tubular voltage-sensor and the Ca2-release units of
the sarcoplasmic reticulum [2^4]. The elucidation of
crucial protein^protein interactions between triad
components and the topology of membrane com-
plexes involved in the regulation and stabilization
of this unique cell biological process is under intense
investigation [5^7]. Many of the key components of
the excitation^contraction^relaxation cycle have been
identi¢ed, i.e. the voltage-sensing K1-dihydropyridine
receptor [8,9] and its auxiliary K2/N-L-Q subunits
[10,11], the ryanodine receptor Ca2-release channel
tetramer [12^14] and its regulatory FKBP12 subunit
[15], the Ca2-binding proteins calsequestrin of the
terminal cisternae [16,17] and sarcalumenin of the
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longitudinal tubules [18], as well as the Ca2-ATPase
isoforms of the sarcoplasmic reticulum [19,20]. How-
ever, it is not fully understood how signal transduc-
tion is mediated by direct triad receptor coupling and
what auxiliary components provide the overall struc-
tural integrity of junctional couplings. Possible can-
didates which might be involved in the prevention of
passive disintegration of junctional proteins and/or
the functional coupling of triad protein complexes
is the 90 kDa JSR-protein [21] and a 95 kDa integral
glycoprotein of the sarcoplasmic reticulum named
triadin [22,23].
Skeletal and cardiac muscle triadins have been
cloned and sequenced [24^26] and shown to exist as
a population of multimeric structures which co-local-
ize with the ryanodine receptor in the junctional sar-
coplasmic reticulum [23,27]. It is not clear whether
triadin provides functional coupling between the
voltage-sensing dihydropyridine receptor and the
ryanodine receptor Ca2-release channel [28,29] or
forms a linkage between the Ca2-binding protein
calsequestrin and the ryanodine receptor [30,31]. Re-
cently, Zhang et al. [32] described a quaternary com-
plex consisting of triadin, the ryanodine receptor,
calsequestrin and the calsequestrin-binding protein
junction in cardiac junctional sarcoplasmic reticu-
lum. The supposition that triadin primarily mediates
intraluminal interactions between calsequestrin and
the ryanodine receptor is supported by its deduced
primary structure [24], as well as domain binding
studies [30]. The analysis of the membrane topology
of triadin monomers indicates that they contain a
single transmembrane domain and that the bulk of
this junctional protein is intraluminal [24,33]. Bind-
ing experiments with fusion proteins representing
various triadin domains showed a Ca2-dependent
interaction between triadin and calsequestrin [30].
Furthermore, interactions between the ryanodine re-
ceptor and triadin domains were found to be re-
stricted to the luminal portion of triadin [30]. On
the other hand, triadin was reported to bind to
both the dihydropyridine receptor and the Ca2-re-
lease channel in blot overlay assays, suggesting a
potential role in triad receptor coupling via cytosolic
domains [34]. It was also shown that antibodies to
triadin a¡ect Ca2-release from the sarcoplasmic re-
ticulum [35]. Based on the analysis of disul¢de bond-
ing, glycosylation and proteolytic degradation, Fan
et al. [36] propose that triadin exhibits more than one
transmembrane domain and mediates interactions
between the II^III loop domain of the K1-dihydro-
pyridine receptor and the ryanodine receptor. In
spite of the above described contradictory ¢ndings,
it is clearly established that triadin is functionally
important for junctional couplings in skeletal muscle
¢bers [37,38].
Comprehensive chemical crosslinking analyses of
triads have shown that tetramers of the Ca2-release
channel and the K1-subunit of the dihydropyridine
receptor exist in a very close neighborhood relation-
ship [39,40], con¢rming the physical coupling hy-
pothesis of excitation^contraction coupling in skele-
tal muscle [2^4]. Calsequestrin was also shown to
form high-molecular-mass complexes above 3000
kDa with the ryanodine receptor in both slow- and
fast-twitch skeletal muscle ¢bers [40,41]. In control
experiments it was demonstrated that the abundant
Ca2-ATPase tetramers [42] are not present in the
above described triad complexes [39,41] illustrating
the speci¢city of chemical crosslinking analysis em-
ploying the hydrophobic 1.2-nm probe dithiobis-suc-
cinimdyl-propionate. Although triadin is a relatively
abundant component of the junctional sarcoplasmic
reticulum [21^24], it was not detectable in chemically
crosslinked triad complexes containing the dihydro-
pyridine receptor, the ryanodine receptor and calse-
questrin [41]. Thus, to further elucidate the mem-
brane topology of native triadin and its potential
interactions with other proteins, we investigated the
con¢guration of disul¢de-bonded triadin polymers
and their neighborhood relationship with the Ca2-
release channel in sarcoplasmic reticulum vesicles.
The immunoblot analysis of high-molecular-mass tri-
adin aggregates was performed using comparative
one- and two-dimensional gel electrophoresis under
reducing and non-reducing conditions, as well as fol-
lowing chemical crosslinking.
2. Materials and methods
2.1. Materials
Chemical crosslinker dithiobis-succinimidyl-propi-
onate and chemiluminescence substrates were pur-
chased from Pierce and Warriner (Chester, UK). Per-
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oxidase-conjugated secondary antibodies, acrylamide
stock solutions and protease inhibitors were obtained
from Boehringer^Mannheim (Lewes, UK). Immobi-
lon NC nitrocellulose membranes were from Milli-
pore Corp. (Bedford, MA, USA). Monoclonal anti-
bodies XIIC4 against sarcalumenin and 20A against
the K2-subunit of the dihydropyridine receptor were
from A⁄nity Bioreagents (Golden, CO, USA). Poly-
clonal antibodies to the ryanodine receptor were pur-
chased from Upstate Biotechnology (Lake Placid,
NY, USA). Monoclonal antibodies IIG12 to triadin,
VIIID12 to calsequestrin and IIID5 to the K1-subunit
of the dihydropyridine receptor were a generous gift
from Dr. Kevin P. Campbell (Howard Hughes Med-
ical Institute, University of Iowa, Iowa City, IA,
USA). All other chemicals were of analytical grade
and purchased from Sigma Chemical Co. (Dorset,
UK).
2.2. Skeletal muscle membrane preparations
Leg and back muscle from New Zealand white
rabbits, which had been obtained from the Biomed-
ical Facility of the National University of Ireland
(Dublin), were homogenized in the presence of a
protease inhibitor cocktail [43]. All preparative steps
were performed at 0^4‡C. Established subcellular
fractionation methods were used to prepare the light
sarcoplasmic reticulum fraction enriched in mem-
branes derived from longitudinal tubules [44], the
triad fraction [39], membranes highly enriched in ex-
tra-junctional transverse tubules [45], and the puri-
¢ed sarcolemma fraction using agglutination with
wheat germ agglutinin [46]. For ¢ber-type speci¢c
immunoblots, microsomal membranes enriched in
triads were prepared from isolated psoas and soleus
muscles [41]. Protein concentration was determined
according to Bradford [47] using myo¢brillar pro-
teins as a standard. For chemical crosslinking anal-
ysis, muscle membranes were incubated at room tem-
perature for 30 min at pH 8 with the homo-
bifunctional 1.2 nm probe dithiobis-succinimidyl-
propionate at a concentration of 50 or 100 Wg cross-
linker per mg membrane protein [48]. The crosslink-
ing reaction was terminated by the addition of am-
monium acetate [39], and subsequently protein
complexes were solubilized in SDS-containing sample
bu¡er under non-reducing conditions [49].
2.3. One- and two-dimensional immunoblot analysis
Electrophoretic separation of membrane proteins
was performed according to Laemmli [49]. Using
the Bio-Rad Protean II xi cell (Bio-Rad Laborato-
ries, Hemel Hempstead, UK), large 3^12% (w/v) gra-
dient SDS^polyacrylamide gels were run for 5000 Vh
at constant voltage with 60 Wg protein per lane (see
Fig. 1). For the comparative analysis of reduced,
non-reduced and chemically crosslinked samples, a
Bio-Rad Mini-Protean II gel system was employed.
One-dimensional 7% (w/v) gels [41] (see Fig. 2) and
diagonal 5% (w/v) non-reducing/6% (w/v) reducing
two-dimensional mini-gels [42] (see Fig. 3) were run
in the ¢rst dimension at a constant voltage for 440 Vh
with 15 Wg protein per lane. The second dimension of
two-dimensional gels was electrophoresed at a con-
stant voltage for varying Vh, optimized for proper
detection of speci¢c antigens in the second dimension
slab gel. Electrophoretic transfer of gels onto Immo-
bilon NC membranes was carried out according to
Towbin et al. [50] using a Hoefer Transfor Cell TE-
52X (Hoefer Scienti¢c Instruments, San Francisco,
CA, USA) for large standard gels and a Bio-Rad
Mini-Protean II blotting system for mini-gels. Nitro-
cellulose sheets were blocked with 5% (w/v) fat-free
milk and incubated with 1:1000 diluted primary anti-
bodies, followed by a washing step and a ¢nal incu-
bation with peroxidase-conjugated secondary anti-
bodies as previously described in detail [39,43].
Visualization of immunodecorated protein bands
was accomplished by enhanced chemiluminescence
methodology [51].
3. Results
3.1. Subcellular expression of triadin in skeletal
muscle
Prior to our one- and two-dimensional immuno-
blot analysis of the relative electrophoretic mobility
of triadin and other key components of excitation^
contraction coupling, we performed a standard sub-
cellular fractionation study. Immunoblotting of sub-
cellular membrane fractions from rabbit skeletal
muscle clearly showed that triadin is highly enriched
in vesicles derived from the triad region of the junc-
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tional sarcoplasmic reticulum (Fig. 1a,b). Longitudi-
nal tubules of the sarcoplasmic reticulum, non-junc-
tional transverse tubules and the sarcolemma do not
appear to contain signi¢cant amounts of triadin. Us-
ing monoclonal antibody IIG12 to triadin, this result
was obtained under both reducing and non-reducing
conditions. Chemical reduction with dithiothreitol,
as illustrated in Fig. 1b, results in a markedly in-
creased electrophoretic mobility of triadin as com-
pared to non-reduced species of this junctional com-
ponent (Fig. 1a). With respect to a ¢ber type-speci¢c
distribution, triadin appears to be present in higher
abundance in predominantly fast-twitching psoas ¢-
bers as compared to the slow soleus muscle (Fig. 1c).
Since we were interested in studying triadin under
non-reducing conditions, in which this protein ap-
pears as a broad band in large polyacrylamide gels
(Fig. 1a), we performed the more detailed analysis of
the spatial relationship between triadin and other
triad proteins with a mini-gel system. In contrast to
the di¡use immunodecorative band in large standard
gels, non-reduced triadin protein, transferred from
mini-gels, was visualized as a distinct band using
enhanced chemiluminescence as a detection system
(Fig. 2a). However, the intensity of this extremely
high-molecular-mass triadin band was relatively
weak. We therefore carried out a more re¢ned im-
munoblot analysis using diagonal non-reducing/re-
ducing two-dimensional gel electrophoresis (Fig. 3).
3.2. Triad complexes in the junctional sarcoplasmic
reticulum
Comparison of the relative electrophoretic mobil-
ity of triadin under reducing versus non-reducing
conditions strongly indicates that triadin behaves
Fig. 1. Subcellular expression of triadin in skeletal muscle.
Shown are immunoblots stained with monoclonal antibody
IIG12 to triadin. Proteins were transferred from 3^12% (w/v)
gradient gels, which had been electrophoresed under non-reduc-
ing conditions (NR) (a) or reducing conditions (R) (b,c). Indi-
vidual lanes in a and b represent membrane preparations en-
riched in longitudinal tubules from the sarcoplasmic reticulum
(LT), triad junctions (TR), extra-junctional transverse tubules
(TT) and the sarcolemma (SL). In c are shown triad prepara-
tions from predominantly fast-twitching psoas muscle and slow-
twitching soleus muscle. Arrowheads indicate the position of
the reduced triadin monomer band of apparent 95 kDa. Disul-
¢de-bridged clusters of triadin are marked by a large open ar-
row. Sizes of molecular mass standards (in kDa), as deduced
from rat myo¢brillar proteins, are indicated on the left.
Fig. 2. Triad complexes in the junctional sarcoplasmic reticu-
lum. Shown are immunoblots of triad couplings isolated from
rabbit skeletal muscle stained with monoclonal antibody IIG12
to triadin (TRI) (a), polyclonal antiserum to the ryanodine re-
ceptor (RyR) (b), monoclonal antibody VIIID12 to calseques-
trin (CSQ) (c), monoclonal antibody IIID5 to the K1-subunit of
the dihydropyridine receptor (K1-DHPR) (d) and monoclonal
antibody 20A to the K2-subunit of the dihydropyridine receptor
(K2-DHPR) (e). Proteins were transferred from 7% (w/v) gels
under reducing conditions (R) (lane 1), non-reducing conditions
(lane 2) or non-reducing conditions following chemical cross-
linking using 50 (lane 3) and 100 (lane 4) Wg dithiobis-succini-
midyl-propionate per mg membrane protein. The position of
immunodecorated monomers is indicated by arrowheads. Sizes
of molecular mass standards (in kDa), as deduced from rat my-
o¢brillar proteins, are indicated on the left.
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like a disul¢de-bridged protein cluster. While reduced
triadin runs at a relative apparent molecular mass of
95 kDa, the estimated size of its non-reduced oligo-
meric structure is above 3000 kDa (Fig. 2a). Since in
the top area of polyacrylamide gels the relationship
between the electrophoretic mobility of a protein and
the logarithm of its molecular mass is not linear [49],
only a comparison to very high-molecular-mass pro-
teins such as titin could give an indication of the
enormous size of the triadin aggregates. Immunoblot
analysis of the ryanodine receptor Ca2-release chan-
nel revealed a major band of apparent 565 kDa
under reducing conditions and two main bands
under non-reducing conditions, one of approximately
2300 kDa and the other one above 3000 kDa (Fig.
2b). The two non-reduced bands probably represent
ryanodine tetramers and large heterogeneous ryano-
dine receptor-containing triad protein complexes, re-
spectively. The top section of the highest molecular
mass band recognized by the polyclonal antibody to
the RyR1-isoform exhibited approximately the same
position as the non-reduced triadin band. Following
chemical crosslinking with the hydrophobic 1.2 nm
probe dithiobis-succinimidyl propionate, the immu-
nodecoration of triadin intensi¢ed and the triadin
band also showed a slight shift to a complex of
even higher relative molecular mass (Fig. 2a). Inter-
estingly, at the lower crosslinker concentration of 50
Wg/mg protein no change in the electrophoretic mo-
bility of the ryanodine receptor was observed. Only a
higher crosslinker concentration caused a shift of all
detectable RyR1-species to the very high-molecular-
mass species (Fig. 2b). Although the resolution of
one-dimensional polyacrylamide gel systems is lim-
ited, these ¢ndings indicate that native triadin is
mostly self-aggregated, but appears to exist in close
proximity to the Ca2-release channel units.
Other abundant triad proteins involved in excita-
tion^contraction coupling, such as the major Ca2-
binding protein calsequestrin and the transverse-tub-
ular dihydropyridine receptor, did not exhibit drastic
changes in their electrophoretic mobility between re-
ducing and non-reducing conditions. None of their
non-reduced protein bands overlapped with the high-
molecular-mass triadin band. Monoclonal antibody
VIIID12 to calsequestrin recognized both the major
calsequestrin monomer of apparent 63 kDa and
high-molecular-mass proteins between 120 kDa and
190 kDa representing calsequestrin-like proteins (Fig.
2c). Antibody labeling of the K1-subunit of the dihy-
dropyridine receptor did not reveal a di¡erence in
relative molecular mass between the reduced and
non-reduced molecule (Fig. 2d), while immunodeco-
Fig. 3. Self-aggregation of triadin in the sarcoplasmic reticulum.
Shown are immunoblots of rabbit muscle membrane proteins
which had been separated by diagonal non-reducing/reducing
two-dimensional gel electrophoresis. Immunodecoration was
performed with monoclonal antibody IIG12 to triadin (TRI)
(a), monoclonal antibody IIID5 to the K1-subunit of the dihy-
dropyridine receptor (K1-DHPR) (b), polyclonal antiserum to
the ryanodine receptor (RyR) (c), monoclonal antibody 20A
against the K2-subunit of the dihydropyridine receptor (d),
monoclonal antibody VIIID12 to calsequestrin (CSQ) (e), as
well as monoclonal antibody XIIC4 against sarcalumenin
(SAR) (f), which also recognizes the sarcoplasmic reticulum gly-
coprotein of 53 kDa (53 kDa GP) (f). Monoclonal antibody
VIIID12 also recognizes calsequestrin-like proteins of higher rel-
ative molecular mass than the 63 kDa calsequestrin monomer
(e). The position of immunodecorated monomers in the second
dimension is marked by arrowheads and sizes of molecular
mass standards (in kDa), as deduced from rat myo¢brillar pro-
teins, are indicated on the left.
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ration of the K2-subunit showed a slight di¡erence in
molecular mass using these two conditions (Fig. 2e).
The decrease in electrophoretic mobility of the re-
duced K2-subunit is due to the loss of N-subunits,
otherwise bound via disul¢de bridges to the larger
subunit of this receptor.
3.3. Self-aggregation of triadin in the sarcoplasmic
reticulum
Since monoclonal antibody IIG12 recognizes tria-
din much more reliably under reducing conditions
and since two-dimensional electrophoretic techniques
have a better resolving power than one-dimensional
systems, we repeated the immunoblot analysis of Fig.
2 with a diagonal two-dimensional gel system as il-
lustrated in Fig. 3. Diagonal non-reducing/reducing
two-dimensional gel electrophoresis is an ideal ana-
lytical procedure for di¡erentiating between protein
species existing as monomers or predominantly as
oligomeric structures in native membranes under
non-reducing conditions. In contrast to chemical
crosslinking techniques, which can give information
about close neighborhood relationships of even
weakly associated complexes, two-dimensional anal-
ysis in the presence of ionic detergent exclusively
recognizes complexes covalently aggregated by disul-
¢de bridges. The combination of these two biochem-
ical techniques can give su⁄cient information to
draw basic conclusions about the spatial con¢gura-
tion of large membrane protein complexes. If a pro-
tein does not change its electrophoretic mobility be-
tween non-reducing and reducing conditions, it runs
on the diagonal of the two-dimensional slab gel. In
stark contrast, if a component of a disul¢de-bonded
high-molecular-mass complex is electrophoresed
under reducing conditions in the second dimension,
a distinct shift o¡ the diagonal is observed.
The comprehensive two-dimensional immunoblot
analysis, as shown in Fig. 3, illustrates this analytical
principle and con¢rms the existence of very large
triadin complexes under non-reducing conditions.
Most importantly, with respect to very high-molec-
ular-mass complexes, no distinct overlap of immu-
noreactivity was observed between the ryanodine re-
ceptor, the K1-dihydropyridine receptor, the K2-
dihydropyridine receptor, calsequestrin, calseques-
trin-like proteins and triadin (Fig. 3a^e). Especially
signi¢cant is the ¢nding that the molecular species
representing the largest complexes of the ryanodine
receptor and triadin di¡er in their electrophoretic
mobility (Fig. 1a,c). This result clari¢es the poten-
tially ambiguous data of one-dimensional immuno-
blot analysis (Fig. 2) and suggests that under non-
reducing conditions both triad components do not
exist as tightly associated supramolecular complexes.
Fig. 4. Diagrammatic presentation of the spatial con¢guration
of key triad components involved in excitation^contraction cou-
pling at skeletal muscle junctional couplings. Shown is the ter-
minal cisternae region, the junctional sarcoplasmic reticulum
membrane and the surface membrane invaginations forming the
transverse tubular system. While the voltage-sensing K1-subunit
of the dihydropyridine receptor (K1-DHPR) is localized to the
transverse tubules, the ryanodine receptor (RyR) Ca2-release
channel is found to be enriched in the junctional sarcoplasmic
reticulum membrane. The major Ca2-binding protein of the
sarcoplasmic reticulum, calsequestrin, is present in the luminal
region of the terminal cisternae. The results presented in this re-
port suggest that triadin exists primarily as large self-aggregates
in the junctional membrane of the sarcoplasmic reticulum.
Although triadin clusters are located in close proximity to the
Ca2-release channel tetramers, this abundant triad component
does not appear to be tightly linked to the other major constit-
uents of skeletal muscle junctional couplings believed to play a
central role in the regulation of the excitation^contraction^re-
laxation cycle and Ca2-homeostasis.
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Thus, although chemical crosslinking implies that
both triadin clusters and ryanodine tetramers exist
in a close neighborhood relationship in the junctional
sarcoplasmic reticulum (Fig. 2a,b), triadin appears to
predominantly form self-aggregated complexes under
native conditions (Fig. 3a). For control purposes,
nitrocellulose replicas of two-dimensional slab gels
were also immunodecorated with monoclonal anti-
body XIIC4 which recognizes sarcalumenin of appar-
ent 160 kDa and the immunologically related 53 kDa
sarcoplasmic reticulum glycoprotein (Fig. 3f). Both
proteins are abundant markers of the sarcoplasmic
reticulum and their immunodecoration pattern did
not overlap with the high-molecular-mass band of
triadin, showing the speci¢city and resolving power
of the two-dimensional gel system employed in this
study.
4. Discussion
The glycoprotein triadin of the skeletal muscle sar-
coplasmic reticulum is an abundant component of
the junctional face membrane and is considered to
play an important role in triad architecture and/or
regulation of Ca2-homeostasis [22^37]. A recent re-
port suggests a potential role for triadin is to act as a
negative regulator of the ryanodine receptor, while
calsequestrin would represent an activator of Ca2-
release units[38]. Our comparative immunoblot anal-
ysis of skeletal muscle triadin employing one- and
two-dimensional gel electrophoresis under reducing
and non-reducing conditions and electrophoretic sep-
aration following chemical crosslinking revealed that
the 95 kDa monomer exists under native conditions
as an extremely high-molecular-mass polymer of
above 3000 kDa. These triadin clusters appear to
be closely located to the ryanodine receptor Ca2-
release channel tetramer. However, a distinct immu-
noreactive overlap between protein bands represent-
ing the two protein complexes was only observed
following chemical crosslinking. Two-dimensional
gel electrophoresis with higher resolving and detec-
tion power than conventional one-dimensional elec-
trophoresis did not reveal a direct coupling between
both triad proteins under non-reducing and non-
crosslinked conditions. This suggests that both pro-
tein species, although they exist in a close neighbor-
hood relationship, are not tightly coupled to each
other. Furthermore, in contrast to other triadic pro-
teins, triadin appears to form mainly self-aggregates
under non-reducing conditions. These results agree
with previous ¢ndings on triad complex formation
in native skeletal muscle vesicles [39^41] and are
summarized diagrammatically in Fig. 4.
The transverse tubular K1-dihydropyridine recep-
tor and the ryanodine receptor of the sarcoplasmic
reticulum form complexes as demonstrated by di¡er-
ential co-immunoprecipitation experiments [52],
binding studies with receptor domains [53] and ultra-
structural co-localization [54]. However, if these triad
receptor complexes are chemically crosslinked, sepa-
rated on a non-reducing gel, excised and then re-
electrophoresed under reducing conditions, the abun-
dant junctional protein triadin is not detectable
[39,41]. Triadin appears to form disul¢de-bonded
homo-polymers which are in the close vicinity, but
not directly linked, to the major triadic complex con-
sisting of the ryanodine receptor, the K1-dihydropyr-
idine receptor and calsequestrin [40]. Consequently
triadin clusters might be of central importance to
the overall structural integrity of junctional couplings
in the muscle periphery and thereby provide indi-
rectly the functional linkage between the luminal
Ca2-reservoir and the Ca2-release units. However,
under physiological conditions direct coupling ap-
pears to be tighter between the two triad receptors
and the major Ca2-binding protein, as compared to
triadin clusters.
Dysgenic myotubes, which are lacking the K1-dihy-
dropyridine receptor, exhibit a reduction in the ex-
pression of triadin and the ryanodine receptor [55].
However, both junctional components are still capa-
ble of forming clusters and attain their mature dis-
tribution with respect to cross-striation [55]. This
would agree with our hypothesis that triadin exists
mainly in self-aggregates and that its association with
the transverse tubules is largely independent of direct
interactions with the K1-subunit of the dihydropyri-
dine receptor complex. Although physical coupling
between the voltage sensor and the Ca2-release
channel underlie excitation^contraction coupling in
mature skeletal muscle ¢bers, triad receptor interac-
tions do not appear to be responsible for the initial
formation and maintenance of junctional couplings
[56]. Other triadic components such as triadin clus-
BBAMEM 77583 6-4-99
G.R. Froemming et al. / Biochimica et Biophysica Acta 1418 (1999) 197^205 203
ters or the 90 kDa JSR protein might be involved in
the actual structural formation of membrane^mem-
brane couplings in the muscle periphery. In the dys-
pedic mouse, which lacks detectable levels of the
ryanodine receptor resulting in perinatal death, tria-
din, calsequestrin and the dihydropyridine receptor
are present [57]. Furthermore, in a transgenic myo-
genic cell line lacking the ryanodine receptor, both
the dihydropyridine receptor and triadin are detect-
able [58,59]. Hence, localization of the Ca2-release
channel to the junctional sarcoplasmic reticulum is
not a prerequisite for the targeting of triadin to the
junctional face membrane in skeletal muscle ¢bers.
This also con¢rms the above described ¢nding that
disul¢de-bonded triadin clusters are not tightly asso-
ciated with other components of the junctional cou-
plings.
It remains to be determined what role triadin oli-
gomerization plays in the development of the excita-
tion^contraction coupling apparatus [60] and
whether triadin exclusively mediates interactions be-
tween the dihydropyridine receptor and the ryano-
dine receptor [34,36] or is involved in functional in-
teractions between calsequestrin and the Ca2-release
channel [30,31]. Elucidation of triadins role in exci-
tation^contraction coupling of mature skeletal
muscle ¢bers can probably only be achieved by re-
¢ned methodological approaches such as future stud-
ies of triadin knock-out mice. Nevertheless, here we
could clearly show that triadin forms large self-ag-
gregates under non-reducing conditions in native
membranes and thus appears not to be directly
linked to the other main triad components implicated
in the regulation of the excitation^contraction^relax-
ation cycle and Ca2-homeostasis. Homo-polymers
of this 95 kDa junctional protein are therefore
good potential candidates for forming the structural
backbone responsible for triad maintenance. Thus in
analogy to the dystrophin^glycoprotein complex,
which stabilizes the sarcolemma during muscle con-
traction by providing a link between the actin mem-
brane cytoskeleton and the extracellular matrix com-
ponent merosin [61], triadin could be one of the
major structural elements mediating the interaction
between the terminal cisternae and the transverse tu-
bules.
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